Both in Pharmaceuticals
Q32 Bio vs Immuneering
Over the past year QTTB returned +217.1% and IMRX returned −45.5%; their daily moves had a correlation of 0.06.
QTTB +217.1% IMRX −45.5%Growth of $1, one year, split-adjusted
| Metric | QTTB | IMRX |
|---|---|---|
| Price | $8.91 | $3.75 |
| Market cap | $265.2M | $242.5M |
| Today | +0.45% | −6.84% |
| 1 month | +8.0% | −7.1% |
| 6 months | +76.8% | −30.3% |
| Year to date | +168.4% | −43.1% |
| 1 year | +232.5% | −40.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | 7.9× | — |
| Price / sales | 4.9× | — |
| Net cash | $106.3M | $145.4M |
| Dividend yield | — | — |
| Volatility (60d) | 62.9% | 50.8% |
| Short % of float | 32.6% | 29.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).